Cargando…
Criteria for Drugs Used in Pre-Exposure Prophylaxis Trials against HIV Infection
The authors formulate criteria for an optimal pre-exposure prophylaxis drug candidate, and evaluate existing antiviral drug classes for their suitability.
Autores principales: | Derdelinckx, Inge, Wainberg, Mark A, Lange, Joep M. A, Hill, Andrew, Halima, Yasmin, Boucher, Charles A. B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1630715/ https://www.ncbi.nlm.nih.gov/pubmed/17090213 http://dx.doi.org/10.1371/journal.pmed.0030454 |
Ejemplares similares
-
Pre-exposure prophylaxis against HIV: pros and cons
por: Wainberg, Mark
Publicado: (2012) -
Rectal artesunate suppositories for the pre-referral treatment of suspected severe malaria
por: Watson, James A., et al.
Publicado: (2023) -
Financing and Delivering Pre-Exposure Prophylaxis (PrEP) to End the HIV Epidemic
por: Killelea, Amy, et al.
Publicado: (2022) -
Health Aspects of the Pre-Departure Phase of
Migration
por: Gushulak, Brian D., et al.
Publicado: (2011) -
Male Circumcision for Prevention of HIV Transmission: What the New Data Mean for HIV Prevention in the United States
por: Sullivan, Patrick S, et al.
Publicado: (2007)